2,3,4,5-tetrahydroxypentanal has been researched along with Disease Models, Animal in 12 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this paper, we have assessed the impact of citrus pectin and modified citrus pectin on colorectal cancer in rats (Rattus norvegicus F344) to which azoxymethane and DSS were supplied." | 8.02 | Behaviour of citrus pectin and modified citrus pectin in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced rat colorectal carcinogenesis model. ( Fernández, J; Ferreira-Lazarte, A; Gallego-Lobillo, P; Lombó, F; Moreno, FJ; Villamiel, M; Villar, CJ, 2021) |
| "Rats were injected with ISO to induce cardiac hypertrophy and treated with MCP." | 5.62 | Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway. ( Li, AY; Li, Y; Liu, WZ; Liu, XC; Song, QH; Sun, JH; Xu, GR; Yang, HX; Zhang, C; Zhang, Y; Zhou, WW, 2021) |
| " In this paper, we have assessed the impact of citrus pectin and modified citrus pectin on colorectal cancer in rats (Rattus norvegicus F344) to which azoxymethane and DSS were supplied." | 4.02 | Behaviour of citrus pectin and modified citrus pectin in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced rat colorectal carcinogenesis model. ( Fernández, J; Ferreira-Lazarte, A; Gallego-Lobillo, P; Lombó, F; Moreno, FJ; Villamiel, M; Villar, CJ, 2021) |
| "Rats were injected with ISO to induce cardiac hypertrophy and treated with MCP." | 1.62 | Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway. ( Li, AY; Li, Y; Liu, WZ; Liu, XC; Song, QH; Sun, JH; Xu, GR; Yang, HX; Zhang, C; Zhang, Y; Zhou, WW, 2021) |
| "Nephrotoxicity is a major toxic effect in chemotherapy, which constitutes up to 60% of hospitalized acute kidney injury (AKI)." | 1.48 | Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity. ( Feng, JX; Li, HY; Li, JC; Yang, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Zhou, WW | 1 |
| Sun, JH | 1 |
| Yang, HX | 1 |
| Xu, GR | 1 |
| Zhang, Y | 1 |
| Song, QH | 1 |
| Zhang, C | 1 |
| Liu, WZ | 1 |
| Liu, XC | 1 |
| Li, AY | 1 |
| Ishisono, K | 1 |
| Mano, T | 1 |
| Yabe, T | 1 |
| Kitaguchi, K | 1 |
| Ferreira-Lazarte, A | 1 |
| Fernández, J | 1 |
| Gallego-Lobillo, P | 1 |
| Villar, CJ | 1 |
| Lombó, F | 1 |
| Moreno, FJ | 1 |
| Villamiel, M | 1 |
| Lu, Y | 1 |
| Zhang, M | 1 |
| Zhao, P | 1 |
| Jia, M | 1 |
| Liu, B | 1 |
| Jia, Q | 1 |
| Guo, J | 1 |
| Dou, L | 1 |
| Li, J | 1 |
| Ibarrola, J | 3 |
| Martínez-Martínez, E | 3 |
| Sádaba, JR | 1 |
| Arrieta, V | 1 |
| García-Peña, A | 1 |
| Álvarez, V | 1 |
| Fernández-Celis, A | 3 |
| Gainza, A | 1 |
| Rossignol, P | 2 |
| Cachofeiro Ramos, V | 1 |
| López-Andrés, N | 4 |
| Fernandez-García, CE | 1 |
| Tarin, C | 1 |
| Roldan-Montero, R | 1 |
| Martinez-Lopez, D | 1 |
| Torres-Fonseca, M | 1 |
| Lindhot, JS | 1 |
| Vega de Ceniga, M | 1 |
| Egido, J | 1 |
| Blanco-Colio, LM | 1 |
| Martín-Ventura, JL | 1 |
| Nguyen, MN | 1 |
| Su, Y | 1 |
| Kiriazis, H | 1 |
| Yang, Y | 1 |
| Gao, XM | 1 |
| McMullen, JR | 1 |
| Dart, AM | 1 |
| Du, XJ | 1 |
| Shtriker, MG | 1 |
| Peri, I | 1 |
| Taieb, E | 1 |
| Nyska, A | 1 |
| Tirosh, O | 1 |
| Madar, Z | 1 |
| Nishikawa, H | 1 |
| Liu, L | 1 |
| Nakano, F | 1 |
| Kawakita, F | 1 |
| Kanamaru, H | 1 |
| Nakatsuka, Y | 1 |
| Okada, T | 1 |
| Suzuki, H | 1 |
| Li, HY | 1 |
| Yang, S | 1 |
| Li, JC | 1 |
| Feng, JX | 1 |
| Matilla, L | 1 |
| Gueret, A | 1 |
| Henry, JP | 1 |
| Nicol, L | 1 |
| Jaisser, F | 1 |
| Mulder, P | 1 |
| Ouvrard-Pascaud, A | 1 |
| Calvier, L | 1 |
| Leroy, C | 1 |
| Cachofeiro, V | 1 |
12 other studies available for 2,3,4,5-tetrahydroxypentanal and Disease Models, Animal
| Article | Year |
|---|---|
Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiovascular Agents; Disease Models, Animal; Gal | 2021 |
Dietary Fiber Pectin Ameliorates Experimental Colitis in a Neutral Sugar Side Chain-Dependent Manner.
Topics: Animals; Colitis; Cytokines; Dextran Sulfate; Dietary Fiber; Disease Models, Animal; Inflammation Me | 2019 |
Behaviour of citrus pectin and modified citrus pectin in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced rat colorectal carcinogenesis model.
Topics: Acetates; Animals; Azoxymethane; Bifidobacterium; Blood Glucose; Body Weight; Butyrates; Carcinogene | 2021 |
Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Diet; Disease Models, Animal; Endothel | 2017 |
Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model.
Topics: Animals; Aorta; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Disease Models, Animal; Galectin 3; | 2017 |
Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Proteins; Case-Control Studies; Cells, | 2017 |
Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
Topics: Amino Sugars; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Galectin 3; Genetic Predi | 2018 |
Galactomannan More than Pectin Exacerbates Liver Injury in Mice Fed with High-Fat, High-Cholesterol Diet.
Topics: Animals; Body Weight; Cholesterol; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Fatty Acid | 2018 |
Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3.
Topics: Animals; Blood-Brain Barrier; Blotting, Western; Brain; Disease Models, Animal; Endothelial Cells; G | 2018 |
Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Apoptosis; Blood Proteins; Caspase 3; Cisplatin; Creatinine; Disease M | 2018 |
Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.
Topics: Animals; Biomarkers; Blood Proteins; Disease Models, Animal; Galectin 3; Galectins; Gene Expression; | 2019 |
Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage.
Topics: Acute Kidney Injury; Animals; Aortic Valve Stenosis; Diet, High-Fat; Disease Models, Animal; Fibrosi | 2016 |